[F:1][C:2]1[CH:3]=[C:4]([CH2:9][OH:10])[CH:5]=[CH:6][C:7]=1[F:8].[H-].[Na+].Cl[C:14]1[CH:15]=[C:16]2[N:23](C(OC(C)(C)C)=O)[C@@H:22]([CH3:31])[CH2:21][N:17]2[C:18](=[O:20])[N:19]=1>O1CCCC1>[F:1][C:2]1[CH:3]=[C:4]([CH:5]=[CH:6][C:7]=1[F:8])[CH2:9][O:10][C:14]1[CH:15]=[C:16]2[NH:23][C@@H:22]([CH3:31])[CH2:21][N:17]2[C:18](=[O:20])[N:19]=1To a solution of (3,4-difluorophenyl)methanol (45.4 mg, 0.315 mmol) in tetrahydrofuran (THF) (3 mL) was added dropwise sodium hydride (37.8 mg, 0.945 mmol) at 0° C. After 30 min, (S)-tert-butyl 7-chloro-2-methyl-5-oxo-2,3-dihydroimidazo[1,2-c]pyrimidine-1(5H)-carboxylate (90 mg, 0.32 mmol) was added. The reaction mixture was stirred at room temperature for 16 h, then concentrated. Purification via pre-TLC (ethyl acetate) afforded the title product.